KeyBioscience (DACRA Pipeline)

KeyBioscience (DACRA Pipeline) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

KeyBioscience (DACRA Pipeline) General Information

Description

Rights to dual amylin calcitonin receptor agonists (DACRA) pipeline. The asset includes global rights to KBP-042-now in Phase II development-as well as KBP-089, KBP-056 and other candidates in phases ranging from pre-clinical to Phase I which are used for type 2 diabetes and other metabolic disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Boonton, NJ
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KeyBioscience (DACRA Pipeline) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KeyBioscience (DACRA Pipeline)‘s full profile, request access.

Request a free trial

KeyBioscience (DACRA Pipeline) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KeyBioscience (DACRA Pipeline)‘s full profile, request access.

Request a free trial